The inhibition of NK cell function by azathioprine during the treatment of patients with rheumatoid arthritis

Br J Rheumatol. 1990 Oct;29(5):358-62. doi: 10.1093/rheumatology/29.5.358.

Abstract

Treatment with azathioprine of patients with rheumatoid arthritis leads to a dramatic reduction in the 4 h NK cytotoxicity against K562 cells. The 24 h cytotoxicity against K562 and U937 cells, however, remains intact. The generation of cell-free supernatant cytotoxic factor(s) after incubating non-adherent mononuclear cells with U937 cells for 24 h is similar in the azathioprine patients and the controls. A large part of this supernatant cytotoxicity is due to tumour necrosis factor alpha which can be inhibited by a specific monoclonal antibody. The mechanism of the reduced 4 h NK cytotoxicity remains unknown but is probably not related to the anti-inflammatory properties of azathioprine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arthritis, Rheumatoid / drug therapy*
  • Azathioprine / therapeutic use*
  • Cytotoxicity, Immunologic
  • Female
  • Humans
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / metabolism
  • Killer Factors, Yeast
  • Male
  • Middle Aged
  • Proteins / metabolism
  • Reference Values
  • Time Factors
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Killer Factors, Yeast
  • Proteins
  • Tumor Necrosis Factor-alpha
  • Azathioprine